060590 — CTC Bio Income Statement
0.000.00%
Last trade - 00:00
- KR₩181bn
- KR₩202bn
- KR₩138bn
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 136,124 | 130,032 | 140,318 | 165,206 | 137,878 |
Cost of Revenue | |||||
Gross Profit | 26,629 | 26,629 | 33,497 | 54,551 | 43,066 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 141,541 | 136,972 | 145,188 | 162,406 | 151,868 |
Operating Profit | -5,417 | -6,940 | -4,870 | 2,799 | -13,989 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13,048 | -22,738 | -7,687 | 199 | -15,715 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13,765 | -22,868 | -7,978 | 4,704 | -15,588 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -13,739 | -19,458 | -7,318 | 4,704 | -15,588 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -13,739 | -19,458 | -7,318 | 4,704 | -15,588 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -674 | -1,023 | -273 | 429 | -403 |
Dividends per Share |